2-(((1H-benzo[d]imidazol-2-yl)sulfinyl)methyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide; 2-[[[4-(3-Methoxypropoxy)-3-methyl-1-oxido-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; 2-[[[1-Oxide-4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; Rabeprazole EP Impurity D
Rabeprazole EP Impurity D is a fully characterized chemical compound used as a reference standard of API Rabeprazole. The standard offered is compliant with regulatory guidelines. Rabeprazole EP Impurity D is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 924663-38-7
Related products
Rabeprazole-d4 Sodium Salt
M.F. C₁₈H₁₆N₃O₃SD₄. Na
M.W. 362.47 22.99
CAT# AR-R01003
CAS# 117976-90-6 (non-labelled)
Racemic-O-Desmethyl Rabeprazole Impurity
M.F. C₁₇H₁₉N₃O₃S
M.W. 345.42
CAT# AR-R01024
CAS# 117976-94-0
Racemic-Desmethyl Rabeprazole Sodium Salt
M.F. C₁₇H₁₈N₃O₃S. Na
M.W. 344.42 22.99
CAT# AR-R01025
CAS# 117976-71-3
Rabeprazole EP Impurity A-d3 (Rabeprazole Sulfone-d3)
M.F. C₁₈H₁₈D₃N₃O₄S
M.W. 378.46
CAT# AR-R01033
CAS# 1330261-33-0
Rabeprazole EP Impurity C
M.F. C₁₄H₁₀N₃O₃ ; Na
M.W. 268.25;22.99
CAT# AR-R09951
CAS# 2437254-50-5 (Na salt)